Tuxarin ER Approval History
- FDA approved: Yes (First approved June 22nd, 2015)
- Brand name: Tuxarin ER
- Generic name: chlorpheniramine and codeine
- Company: Spriaso LLC
- Treatment for: Cough, Cold Symptoms
Tuxarin ER (codeine and chlorpheniramine) is a long acting narcotic antitussive and antihistamine combination for the treatment of cough and cold symptoms.
Development History and FDA Approval Process for Tuxarin ER
|Jul 1, 2015||Spriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine)|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.